EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

A theranostic photosensitizer-conjugated albumin co-loading with resiquimod for cancer-targeted imaging and robust photo-immunotherapy

Xu Tan, Yu Wang, Lei Long, Hongdan Chen, Langfan Qu, Xiaohui Cao, Huijuan Li, Zelin Chen, Shenglin Luo, Chunmeng Shi

Pharmacological Research · 2024

DOI: 10.1016/j.phrs.2024.107489 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmacological Research, 2024. Verfasst von Xu Tan und 9 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Rocket Force Medicine, State Key Laboratory of Trauma and Chemical Poisoning, College of Preventive Medicine, Army Medical University, G…. Hauptthemen laut MEDLINE: Photosensitizing Agents, Imidazoles, Immunotherapy, Serum Albumin, Human. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cancer immunotherapy remains a low immune response rate in clinic because of dominant immunosuppressive tumor microenvironment (TME) and lack of effective drug to specifically remodel the TME. In this work, we introduced a tumor-seeking human serum albumin (HSA) based delivery platform by covalently conjugating with a tumor-targeting near-infrared (NIR) photosensitizer (IR-DBI) and non-covalently loading of immune modulator Resiquimod (R848). HSA exhibited tumor-preferential accumulation after covalent conjugation with IR-DBI. Meanwhile, HSA restricted the rotation of IR-DBI, narrowed the HOMO-LUMO energy gap, significantly enhanced fluorescent intensity and dual-modal phototherapy (PTT/PDT). The enhanced phototherapeutic effect further induced robust ICD effect. More importantly, non-covalent loading of R848 could be released from HSA at tumor sites by laser irradiation-induced heat. The in-situ release of R848 in TME efficiently promoted the maturation of DC cells and repolarized M2 macrophages to M1 macrophages. Consequently, robust photo-induced antitumor immunity was triggered in the different mice models bearing primary and distant tumors or lung metastasis, which was further enhanced by combining with CTLA-4 blockade therapy. Taken together, this work may present a versatile albumin composite which exhibits tumor-preferential accumulation and imaging-guided PDT/PTT/immunotherapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Photosensitizing AgentsImidazolesImmunotherapySerum Albumin, HumanAnimalsHumansMiceCell Line, TumorPhotochemotherapyTheranostic NanomedicineFemaleTumor MicroenvironmentMice, Inbred C57BLMice, Inbred BALB CNeoplasmsPhototherapyAntineoplastic Agents

Stichwörter der Autor:innen

CTLA-4 blockade therapyCancer immunotherapyDual-modal phototherapyHuman serum albuminTumor microenvironment

Substanzen

Photosensitizing AgentsImidazolesresiquimodSerum Albumin, HumanAntineoplastic Agents

Autor:innen und Institutionen

  • Institute of Rocket Force Medicine, State Key Laboratory of Trauma and Chemical Poisoning, College of Preventive Medicine, Army Medical University, Gaotanyan Street 30, Chongqing 400038, China.
  • Department of Breast and Thyroid Surgery, Chongqing General Hospital, Xingguang Road 118, Chongqing 401121, China.
  • Institute of Rocket Force Medicine, State Key Laboratory of Trauma and Chemical Poisoning, College of Preventive Medicine, Army Medical University, Gaotanyan Street 30, Chongqing 400038, China. Electronic address: czlwx…
  • Institute of Combined Injury, State Key Laboratory of Trauma and Chemical Poisoning, Chongqing Engineering Research Center for Nanomedicine, College of Preventive Medicine, Army Medical University, Gaotanyan Street 30,…
  • Institute of Rocket Force Medicine, State Key Laboratory of Trauma and Chemical Poisoning, College of Preventive Medicine, Army Medical University, Gaotanyan Street 30, Chongqing 400038, China. Electronic address: shicm…

Zitieren

APA

Tan, X., Wang, Y., Long, L., Chen, H., Qu, L., Cao, X., Li, H., Chen, Z., Luo, S., & Shi, C. (2024). A theranostic photosensitizer-conjugated albumin co-loading with resiquimod for cancer-targeted imaging and robust photo-immunotherapy. Pharmacological Research. https://doi.org/10.1016/j.phrs.2024.107489

Vancouver

Tan X, Wang Y, Long L, Chen H, Qu L, Cao X, et al. A theranostic photosensitizer-conjugated albumin co-loading with resiquimod for cancer-targeted imaging and robust photo-immunotherapy. Pharmacological Research. 2024. doi:10.1016/j.phrs.2024.107489

BibTeX
@article{Tan2024,
  author = {Tan, Xu and Wang, Yu and Long, Lei and Chen, Hongdan and Qu, Langfan and Cao, Xiaohui and Li, Huijuan and Chen, Zelin and Luo, Shenglin and Shi, Chunmeng},
  title = {A theranostic photosensitizer-conjugated albumin co-loading with resiquimod for cancer-targeted imaging and robust photo-immunotherapy},
  journal = {Pharmacological Research},
  year = {2024},
  doi = {10.1016/j.phrs.2024.107489}
}
Kostenlos starten →